EX-21.1 6 ex21-1.htm

Exhibit 21.1

Subsidiaries of Sanara MedTech Inc.

The following is a list of subsidiaries of Sanara MedTech Inc., a Texas corporation (the “Company”), as of December 31, 2022, the states in which they are organized and the Company’s percentage ownership of the issued and outstanding stock or other equity interests for each entity. The names of particular subsidiaries may be omitted if the unnamed subsidiaries, considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary as of the end of the year covered by the annual report on Form 10-K of which this Exhibit 21.1 forms a part. (See the definition of “significant subsidiary” in Rule 1-02(w) (17 CFR 210.1-02(w)) of Regulation S-X.)

Name of Subsidiary |  | State of Incorporation |  | Direct or Indirect Ownership Percentage |
Cellerate, LLC |  | Texas |  |  | 100 | %
Wound Care Innovations, LLC |  | Nevada |  |  | 100 | %
Sanara Biologics, LLC |  | Texas |  |  | 100 | %
Rochal Technologies, LLC |  | Texas |  |  | 100 | %
WounDerm, LLC |  | Delaware |  |  | 100 | %(1)
United Wound and Skin Solutions, LLC |  | Delaware |  |  | 100 | %
Precision Healing, LLC |  | Delaware |  |  | 100 | %(1)
Scendia Biologics, LLC |  | Delaware |  |  | 100 | %

(1) Ownership of WounDerm, LLC and Precision Healing, LLC is held indirectly through United Wound and Skin Solutions, LLC, a wholly owned subsidiary of the Company.